Baseline characteristics | T1D (480) | T2D (442) | Significance (P value) | ||
---|---|---|---|---|---|
PT1D (332) | NT1D (148) | PT2D (266) | NT2D (176) | ||
Age (years) (mean ± sd) | 27.3 ± 0.5 | 26.5 ± 9.6 | 47.6 ± 13.1 | 42.6 ± 10.7 | < 0.001 |
Gender | < 0.001 | ||||
Male | 150 (45.2) | 107 (72.3) | 182 (68.4) | 136 (77.3) | |
Female | 182 (54.8) | 41 (27.7) | 84 (31.6) | 40 (22.7) | |
Ethnicities | < 0.001 | ||||
Arabic | 252 (76) | 76 (51.4) | 124 (46.6) | 50 (28.4) | |
Asian | 46 (13.9) | 42 (28.4) | 119 (44.8) | 93 (52.8) | |
Africans | 23 (6.9) | 26 (17.6) | 15 (5.6) | 26 (14.8) | |
Others | 11 (3.3) | 4 (2.7) | 8 (3) | 7 (4) | |
BMI kg/m2a | < 0.001 | ||||
Asians | |||||
Normal (< 23) | 35 (76.1) | 24 (58.5) | 45 (38.5) | 33 (35.9) | |
Overweight (23–24.9) | 8 (17.4) | 3 (7.3) | 21 (17.9) | 12 (13) | |
Obese (≥ 25) | 3 (6.5) | 14 (34.1) | 51 (43.6) | 47 (51.1) | |
Others | < 0.001 | ||||
Normal (< 25) | 189 (66.5) | 70 (67.3) | 59 (40.1) | 20 (24.1) | |
Overweight (25–26.9) | 54 (19) | 22 (21.1) | 41 (27.9) | 33 (39.7) | |
Obese (≥ 27) | 41 (14.4) | 12 (11.5) | 47 (31.9) | 30 (36.1) | |
Comorbidities | |||||
Dyslipidaemia (128) | 30 (9) | 6 (4) | 70 (26.3) | 22 (12.5) | < 0.001 |
Hypertension (199) | 40 (12) | 5 (3.3) | 103 (38.7) | 51 (28.9) | < 0.001 |
Stroke (260) | 3 (0.9) | 0 | 16 (6) | 7 (3.9) | < 0.001 |
Coronary artery disease (56) | 13 (3.9) | 2 (1.3) | 32 (12) | 9 (5.1) | < 0.001 |
Retinopathy (78) | 33 (9.9) | 0 | 39 (14.6) | 6 (3.4) | < 0.001 |
Nephropathy (60) | 19 (5.7) | 0 | 35 (13.1) | 6 (3.4) | < 0.001 |
Diabetic Foot (25) | 5 (1.5) | 0 | 18 (6.7) | 2 (1.1) | < 0.001 |
Microvascular complications of DM (95) | 36 (10.8) | 0 | 49 (18.4) | 10 (5.6) | < 0.001 |
Macrovascular complications of DM (56) | 13 (3.9) | 2 (1.3) | 32 (12) | 9 (5.1) | < 0.001 |
Metabolic risk (394) | 85 (25.6) | 34 (22.9) | 166 (62.4) | 109 (61.9) | < 0.001 |
Consult to diabetes educator (348) | 60 (18) | 68 (45.9) | 120 (45.1) | 100 (56.8) | < 0.001 |